Radiant Biotherapeutics
A biotechnology company developing the next generation of multi-specificity.
Launch date
Employees
Market cap
-
Enterprise valuation
$140—210m (Dealroom.co estimates Sep 2024.)
Toronto Ontario (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
* | $100k | Grant | |
* | $8.0m | Seed | |
* | $2.0m | Grant | |
* | $35.0m | Series A | |
Total Funding | $45.1m |